Renowned nephrologist and quality of care advocate will lead clinical programs and provider teams in delivering evidence-based, patient-centered care DENVER–(BUSINESSRenowned nephrologist and quality of care advocate will lead clinical programs and provider teams in delivering evidence-based, patient-centered care DENVER–(BUSINESS

Strive Health Welcomes Keith Bellovich, D.O., as Chief Nephrologist to Advance Kidney Care Excellence

Renowned nephrologist and quality of care advocate will lead clinical programs and provider teams in delivering evidence-based, patient-centered care

DENVER–(BUSINESS WIRE)–Strive Health, the national leader in value-based kidney care, welcomes Keith Bellovich, D.O., as its Chief Nephrologist. In this role, Dr. Bellovich will partner with the Chief Clinical Officer and other clinical leadership to drive the development of clinical programs, establish best-practice protocols and oversee a team of providers dedicated to delivering high-quality, evidence-based care for people living with kidney disease.

“Dr. Bellovich brings exactly the combination of clinical expertise and collaborative leadership we need at this moment,” said Chris Riopelle, Co-Founder and CEO of Strive. “His proven track record in advancing quality standards across the kidney care spectrum — combined with his dedication to evidence-based medicine and patient advocacy — will be invaluable as we continue improving outcomes for the people we serve.”

Dr. Bellovich has been a passionate advocate for kidney disease prevention and quality improvement at the national level throughout his career. Before joining Strive, Dr. Bellovich served as Chief Medical Officer at Henry Ford St. John Hospital in his hometown of Detroit. He also served as Medical Director of acute kidney care across eight Michigan hospitals, where he provided extracorporeal therapy and led clinical investigations focused on kidney disease.

He is the immediate past president of the Renal Physicians Association and has been actively involved with the Kidney Care Quality Alliance, Kidney Care Partners and the American Board of Internal Medicine’s Liaison Committee on Certification and Recertification.

Dr. Bellovich began his career in private practice at St. Clair Nephrology in Michigan. He earned his medical degree from the Michigan State University College of Osteopathic Medicine and completed his nephrology fellowship at Henry Ford Hospital. He recently completed a Master of Business Administration at the University of Michigan Ross School of Business.

“I’m honored to join Strive at such a pivotal moment in kidney care,” Dr. Bellovich said. “Strive’s commitment to patient-centered care and clinical excellence aligns fully with my vision for what kidney care should be. I look forward to working alongside our talented team to ensure we continue exceeding the standards of care our patients deserve and bring value to the entire healthcare system.”

To learn more about Strive and its growing executive team, visit https://strivehealth.com/.

ABOUT STRIVE HEALTH

Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology — including AI — care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 145,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.

Contacts

MEDIA CONTACT:
Nicole Leatherman

Strive Health Communications

619-917-4807

nleatherman@strivehealth.com

Market Opportunity
DAR Open Network Logo
DAR Open Network Price(D)
$0.01199
$0.01199$0.01199
-5.73%
USD
DAR Open Network (D) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

JPMorgan’s Sobering Reality Check On The $1 Trillion Dream

JPMorgan’s Sobering Reality Check On The $1 Trillion Dream

The post JPMorgan’s Sobering Reality Check On The $1 Trillion Dream appeared on BitcoinEthereumNews.com. Imagine a world where stablecoins, the digital dollars
Share
BitcoinEthereumNews2025/12/19 07:07
Will XRP Price Increase In September 2025?

Will XRP Price Increase In September 2025?

Ripple XRP is a cryptocurrency that primarily focuses on building a decentralised payments network to facilitate low-cost and cross-border transactions. It’s a native digital currency of the Ripple network, which works as a blockchain called the XRP Ledger (XRPL). It utilised a shared, distributed ledger to track account balances and transactions. What Do XRP Charts Reveal? […]
Share
Tronweekly2025/09/18 00:00
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56